APE-STUDY: ABLATION OF BARRETT'S MUCOSA VS. SURVEILLANCE WITHOUT ABLATION IN PATIENTS CURED FROM BARRETT'S CANCER COMBINED WITH RANDOMIZATION OF ESOMEPRAZOLE VS. PLACEBO FOR SYMPTOMATIC REFLUX CONTROL AFTER SUCCESSFUL BARRETT'S ABLATION: